# Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery

> **NCT01825720** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 106 (actual)

## Conditions studied

- Valvular Heart Disease

## Interventions

- **DRUG:** (Glucose-Insulin-Potassium)GIK group
- **DRUG:** normal saline group

## Key facts

- **NCT ID:** NCT01825720
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2013-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825720, "Effect of Glucose-Insulin-Potassium on Hyperlactatemia in Patients Undergoing Valvular Heart Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01825720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*